FLOaTing toward new standards in locally advanced resectable gastroesophageal cancer.
作者信息
Fornaro Lorenzo, Vivaldi Caterina, Calvetti Lorenzo, Cappetta Alessandro, Falcone Alfredo, Aprile Giuseppe
机构信息
Unit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
出版信息
J Thorac Dis. 2019 Dec;11(12):5694-5700. doi: 10.21037/jtd.2019.12.103.
Abstract
摘要
相似文献
1
FLOaTing toward new standards in locally advanced resectable gastroesophageal cancer.迈向局部进展期可切除性胃食管癌新标准。
J Thorac Dis. 2019 Dec;11(12):5694-5700. doi: 10.21037/jtd.2019.12.103.
2
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.可切除、交界可切除和局部进展期胰腺癌新辅助治疗的意见和应用：国际调查和病例简述研究。
BMC Cancer. 2019 Jul 9;19(1):675. doi: 10.1186/s12885-019-5889-5.
3
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.局部进展期胰腺导管腺癌可切除性判断的共识——Conko-007 多中心试验结果。
BMC Cancer. 2019 Oct 22;19(1):979. doi: 10.1186/s12885-019-6148-5.
4
Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?局部晚期胃食管癌的管理：仍然是一项多学科的全球挑战？
Hematol Oncol Clin North Am. 2017 Jun;31(3):441-452. doi: 10.1016/j.hoc.2017.01.004. Epub 2017 Mar 29.
5
Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society.日本胰腺学会制定的胰腺癌新可切除性标准的评估与建议。
Surgery. 2017 Oct;162(4):784-791. doi: 10.1016/j.surg.2017.04.023. Epub 2017 Jun 24.
6
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.紫杉醇与同步放射治疗用于局部晚期胰腺癌、胃癌及胃食管交界腺癌
Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):53-7.
7
Locally advanced gastroesophageal junction tumor: a treatment dilemma.局部晚期胃食管交界部肿瘤：治疗难题
Oncologist. 2015 Feb;20(2):134-42. doi: 10.1634/theoncologist.2014-0377. Epub 2015 Jan 5.
8
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.可切除边缘性和局部进展性不可切除胰腺癌的当代管理
Oncologist. 2016 Feb;21(2):178-87. doi: 10.1634/theoncologist.2015-0316. Epub 2016 Feb 1.
9
Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.新辅助FOLFIRINOX方案治疗后可切除胰腺癌的完全病理缓解——病例报告及文献复习
BMC Cancer. 2016 Oct 10;16(1):786. doi: 10.1186/s12885-016-2821-0.
10
Strategies to improve the outcome in locally advanced pancreatic cancer.改善局部晚期胰腺癌治疗效果的策略。
Minerva Chir. 2015 Apr;70(2):97-106. Epub 2015 Feb 6.
引用本文的文献
1
Recent Noteworthy Studies in Thoracic Oncology.近期胸部肿瘤学的重要研究
Ann Surg Oncol. 2025 Mar;32(3):1610-1616. doi: 10.1245/s10434-024-16353-y. Epub 2024 Oct 15.
2
Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network.基于多西紫杉醇的新辅助化疗后整块切除术治疗食管腺癌：来自区域上消化道癌症网络的 15 年回顾性分析。
Ann Surg Oncol. 2024 Apr;31(4):2461-2469. doi: 10.1245/s10434-023-14779-4. Epub 2023 Dec 23.
本文引用的文献
1
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.Ⅱ-Ⅲ期胃癌和胃食管结合部癌的多学科综合治疗。
Eur J Cancer. 2020 Jan;124:67-76. doi: 10.1016/j.ejca.2019.09.006. Epub 2019 Nov 20.
2
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.胃癌中微卫星不稳定性作为生物标志物价值的个体化患者数据汇总分析。
J Clin Oncol. 2019 Dec 10;37(35):3392-3400. doi: 10.1200/JCO.19.01124. Epub 2019 Sep 12.
3
Recent eUpdates to the ESMO Clinical Practice Guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancer.欧洲肿瘤内科学会（ESMO）肝细胞癌、胰腺癌、软组织和内脏肉瘤、前列腺癌及胃癌临床实践指南的近期电子更新内容。
Ann Oncol. 2019 Aug 1;30(8):1395-1397. doi: 10.1093/annonc/mdz180.
4
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗（FLOT4）：一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
5
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions.局部晚期胃食管交界癌：近期治疗进展与研究方向。
Cancer Treat Rev. 2018 Sep;69:90-100. doi: 10.1016/j.ctrv.2018.06.012. Epub 2018 Jun 18.
7
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.胃食管交界部癌系统治疗反应的遗传学预测因子。
Cancer Discov. 2018 Jan;8(1):49-58. doi: 10.1158/2159-8290.CD-17-0787. Epub 2017 Nov 9.
8
Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer.胃癌患者围手术期化疗完成情况的预测因素及其预后意义。
J Gastrointest Surg. 2017 Dec;21(12):1984-1992. doi: 10.1007/s11605-017-3594-8. Epub 2017 Sep 29.
9
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).ICORG 10 - 14：食管腺癌和食管胃交界腺癌国际研究（Neo - AEGIS）的新辅助试验
BMC Cancer. 2017 Jun 3;17(1):401. doi: 10.1186/s12885-017-3386-2.
10
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.TOPGEAR：一项可切除胃癌围手术期 ECF 化疗联合或不联合术前放化疗的随机 III 期临床试验：AGITG、TROG、EORTC 和 CCTG 国际多组试验的中期结果。
Ann Surg Oncol. 2017 Aug;24(8):2252-2258. doi: 10.1245/s10434-017-5830-6. Epub 2017 Mar 23.
Zotero 插件